1Department of Pulmonology, North Lisbon University Hospital Centre, Portugal.
2Department of Radiology, North Lisbon University Hospital Centre, Portugal.
*Corresponding Author : Francisca Godinho Oliveira
Department of Pulmonology, North Lisbon University Centre, Portugal.
Email: [email protected]
Received : Feb 10, 2023
Accepted : Feb 10, 2023
Published : Mar 03, 202
Archived : www.jcimcr.org
Copyright : © Oliveira FG (2023).
Keywords: Pulmonary arterial aneurysms; Behcet syndrome; Arterial embolization.
A 28-year-old non-smoker male with Behçet syndrome presented with recurrent oral/genital ulcers and erythema nodosum, giant pulmonary arterial saccular aneurysms (Figure 1 A-D) with recurrent hemoptysis and a pulmonary nodule with biopsy suggestive of necrotizing vasculitis.
The patient was initially treated with methylprednisolone and cyclophosphamide with no clinical or imaging response (Figure 1 A-D). Immunosuppression was changed to infliximab and azathioprine with corticosteroid therapy at higher doses. Due to persistent hemoptysis, the patient underwent endovascular arterial embolization with coiling and cyanoacrylate-lipiodol mixture of three large pulmonary aneurysms, resulting in decrease in size of aneurysms and temporary control of the symptoms (Figure 1 E-H). Surgical lung resection was not considered appropriate due to the extension of the disease and the patient was referred for lung transplantation. The patient died shortly afterwards as a result of fulminant hemoptysis in the intensive care unit.
Behçet syndrome is a multisystemic vasculitis affecting arteries and veins from all sizes. Pulmonary arterial aneurysms are the most common pulmonary vascular lesions in Behçet syndrome [1] and are more common among males [2]. Hemoptysis is the most frequent presenting symptom [1].
Pulmonary arterial aneurysms suggest a poor prognosis being a life-threatening complication of Behçet syndrome. Medical, endovascular and surgical treatments have been used, usually with poor outcomes [2]. The choice of appropriate treatment should take into account the severity of the hemoptysis and also the number and localization of pulmonary arterial aneurysms. Recently, anti-TNF alpha treatment has shown promissive results in severe refractory Behçet´s disease [3].